168 related articles for article (PubMed ID: 27245902)
21. Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons.
Keimpema E; Tortoriello G; Alpár A; Capsoni S; Arisi I; Calvigioni D; Hu SS; Cattaneo A; Doherty P; Mackie K; Harkany T
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1935-40. PubMed ID: 23319656
[TBL] [Abstract][Full Text] [Related]
22. 2-Arachidonoylglycerol is a substrate for butyrylcholinesterase: A potential mechanism for extracellular endocannabinoid regulation.
Barricklow J; Blatnik M
Arch Biochem Biophys; 2013 Aug; 536(1):1-5. PubMed ID: 23689009
[TBL] [Abstract][Full Text] [Related]
23. Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.
Mulder J; Zilberter M; Pasquaré SJ; Alpár A; Schulte G; Ferreira SG; Köfalvi A; Martín-Moreno AM; Keimpema E; Tanila H; Watanabe M; Mackie K; Hortobágyi T; de Ceballos ML; Harkany T
Brain; 2011 Apr; 134(Pt 4):1041-60. PubMed ID: 21459826
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes.
Saario SM; Salo OM; Nevalainen T; Poso A; Laitinen JT; Järvinen T; Niemi R
Chem Biol; 2005 Jun; 12(6):649-56. PubMed ID: 15975510
[TBL] [Abstract][Full Text] [Related]
25. Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus.
Yoshida T; Uchigashima M; Yamasaki M; Katona I; Yamazaki M; Sakimura K; Kano M; Yoshioka M; Watanabe M
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):3059-64. PubMed ID: 21282604
[TBL] [Abstract][Full Text] [Related]
26. Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.
Grabner GF; Zimmermann R; Schicho R; Taschler U
Pharmacol Ther; 2017 Jul; 175():35-46. PubMed ID: 28213089
[TBL] [Abstract][Full Text] [Related]
27. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
Shimizu T; Tanaka K; Shimizu S; Higashi Y; Yawata T; Nakamura K; Taniuchi K; Ueba T; Yuri K; Saito M
Neuropharmacology; 2015 Aug; 95():278-89. PubMed ID: 25882827
[TBL] [Abstract][Full Text] [Related]
28. Substrate selectivity of bacterial monoacylglycerol lipase based on crystal structure.
Tsurumura T; Tsuge H
J Struct Funct Genomics; 2014 Sep; 15(3):83-9. PubMed ID: 24894647
[TBL] [Abstract][Full Text] [Related]
29. 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism.
Jung KM; Clapper JR; Fu J; D'Agostino G; Guijarro A; Thongkham D; Avanesian A; Astarita G; DiPatrizio NV; Frontini A; Cinti S; Diano S; Piomelli D
Cell Metab; 2012 Mar; 15(3):299-310. PubMed ID: 22405068
[TBL] [Abstract][Full Text] [Related]
30. Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons.
Straiker A; Hu SS; Long JZ; Arnold A; Wager-Miller J; Cravatt BF; Mackie K
Mol Pharmacol; 2009 Dec; 76(6):1220-7. PubMed ID: 19767452
[TBL] [Abstract][Full Text] [Related]
31. Discovery of potent and reversible monoacylglycerol lipase inhibitors.
King AR; Dotsey EY; Lodola A; Jung KM; Ghomian A; Qiu Y; Fu J; Mor M; Piomelli D
Chem Biol; 2009 Oct; 16(10):1045-52. PubMed ID: 19875078
[TBL] [Abstract][Full Text] [Related]
32. Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice.
Vujic N; Schlager S; Eichmann TO; Madreiter-Sokolowski CT; Goeritzer M; Rainer S; Schauer S; Rosenberger A; Woelfler A; Doddapattar P; Zimmermann R; Hoefler G; Lass A; Graier WF; Radovic B; Kratky D
Atherosclerosis; 2016 Jan; 244():9-21. PubMed ID: 26584135
[TBL] [Abstract][Full Text] [Related]
33. Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.
Ueda N; Tsuboi K; Uyama T; Ohnishi T
Biofactors; 2011; 37(1):1-7. PubMed ID: 21328621
[TBL] [Abstract][Full Text] [Related]
34. Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol.
Petrenko AB; Yamazaki M; Sakimura K; Kano M; Baba H
Behav Brain Res; 2014 Sep; 271():51-8. PubMed ID: 24906199
[TBL] [Abstract][Full Text] [Related]
35. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.
Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R
Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854
[TBL] [Abstract][Full Text] [Related]
36. 2-AG + 2 new players = forecast for therapeutic advances.
Marrs W; Stella N
Chem Biol; 2007 Dec; 14(12):1309-11. PubMed ID: 18096497
[TBL] [Abstract][Full Text] [Related]
37. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation.
Dinh TP; Freund TF; Piomelli D
Chem Phys Lipids; 2002 Dec; 121(1-2):149-58. PubMed ID: 12505697
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus.
Makara JK; Mor M; Fegley D; Szabó SI; Kathuria S; Astarita G; Duranti A; Tontini A; Tarzia G; Rivara S; Freund TF; Piomelli D
Nat Neurosci; 2005 Sep; 8(9):1139-41. PubMed ID: 16116451
[TBL] [Abstract][Full Text] [Related]
39. Fever Is Mediated by Conversion of Endocannabinoid 2-Arachidonoylglycerol to Prostaglandin E2.
Kita Y; Yoshida K; Tokuoka SM; Hamano F; Yamazaki M; Sakimura K; Kano M; Shimizu T
PLoS One; 2015; 10(7):e0133663. PubMed ID: 26196692
[TBL] [Abstract][Full Text] [Related]
40. Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.
Pertwee RG
Proc Nutr Soc; 2014 Feb; 73(1):96-105. PubMed ID: 24135210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
